Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc.（CRL）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · CRL · 截至 2025年9月30日
股东结构概览
571
机构持有人数
▲ 27 vs Q2
$7.92B
机构持仓总市值
▲ $188.11M vs Q2
48.17M
总流通股
freeFloat 98.80%
50.44M
13F 申报持股数
▼ 460,109 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
CRL 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC services-commercial physical & biological research | 5.84M | 11.88% | 11.88% | $913.69B | Nov 7, 2025 | ▲ 28.0K |
BLACKROCK, INC. services-commercial physical & biological research | 3.86M | 7.85% | 7.85% | $603.32B | Nov 12, 2025 | ▲ 199.9K |
WELLINGTON MANAGEMENT GROUP LLP services-commercial physical & biological research | 3.19M | 6.49% | 6.49% | $499.18B | Nov 14, 2025 | ▼ 577.3K |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC services-commercial physical & biological research | 2.18M | 4.43% | 4.43% | $371.30B | Oct 20, 2025 | ▼ 113.2K |
STATE STREET CORP services-commercial physical & biological research | 1.83M | 3.73% | 3.73% | $286.50B | Nov 14, 2025 | ▼ 27.6K |
ARIEL INVESTMENTS, LLC services-commercial physical & biological research | 1.49M | 3.03% | 3.03% | $233.14B | Nov 14, 2025 | ▲ 74.8K |
HARRIS ASSOCIATES L P services-commercial physical & biological research | 1.47M | 3.00% | 3.00% | $230.48B | Nov 14, 2025 | ▲ 310.1K |
GEODE CAPITAL MANAGEMENT, LLC services-commercial physical & biological research | 1.27M | 2.58% | 2.58% | $197.82B | Nov 12, 2025 | ▲ 34.5K |
INVESCO LTD. services-commercial physical & biological research | 1.25M | 2.54% | 2.54% | $195.45B | Nov 13, 2025 | ▲ 12.0K |
BANK OF AMERICA CORP /DE/ services-commercial physical & biological research | 1.16M | 2.37% | 2.37% | $182.02B | Feb 3, 2026 | ▲ 137.3K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
32
增持
+4.74M 股0
新建仓
首次建仓18
减持
−2.37M 股0
清仓
完全退出净股数变化（前50家）
+2.37M
+4.74M / −2.37M
净新增持仓人
+14
新建 0 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
CRL 内幕交易记录
数据来源：SEC Form 4
25
买入笔数
26
卖出笔数
0.96
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Barg Steven director | Jun 2, 2026 | Award | 422 | $174.79 | $73.8K | 3.3K | Form 4 ↗ |
Coleman Glenn EVP & Chief Financial Officer | May 29, 2026 | Award | 6,640 | $180.71 | $1.20M | 27.8K | Form 4 ↗ |
Mintz Mark EVP, Chief Information Officer | May 29, 2026 | Award | 2,534 | $180.71 | $457.9K | 9.9K | Form 4 ↗ |
Mintz Mark EVP, Chief Information Officer | May 30, 2026 | Tax Withhold | 305 | $180.71 | $55.1K | 9.6K | Form 4 ↗ |
Mintz Mark EVP, Chief Information Officer | May 31, 2026 | Tax Withhold | 64 | $180.71 | $11.6K | 9.5K | Form 4 ↗ |
LaPlume Joseph W EVP, Corp Strategy & Develop | May 29, 2026 | Award | 5,257 | $180.71 | $950.0K | 32.3K | Form 4 ↗ |
LaPlume Joseph W EVP, Corp Strategy & Develop | May 30, 2026 | Tax Withhold | 744 | $180.71 | $134.4K | 31.5K | Form 4 ↗ |
LaPlume Joseph W EVP, Corp Strategy & Develop | May 31, 2026 | Tax Withhold | 235 | $180.71 | $42.5K | 31.3K | Form 4 ↗ |
Knell Michael Gunnar SVP, Finance and CAO | May 29, 2026 | Award | 1,837 | $180.71 | $332.0K | 16.4K | Form 4 ↗ |
Knell Michael Gunnar SVP, Finance and CAO | May 30, 2026 | Tax Withhold | 152 | $180.71 | $27.5K | 16.2K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Charles River Laboratories International, Inc.（CRL）主要由机构投资者持有，机构持股比例约为 100.0%。公司内部人员持股约 1.20%，散户及公众持股约占剩余的 0.00%。
Charles River Laboratories International, Inc. 最大机构股东为 VANGUARD GROUP INC，截至 September 30, 2025 持有约 5.84 million 股，占总流通股的 11.88%。
目前共有 571 家机构持有 CRL 股票，合计持仓市值约 $7.92 billion，数据来源为最新 SEC 13F 申报。
常见问题
CRL ownershipCharles River Laboratories International, Inc.（CRL）主要由机构投资者持有，机构持股约 100.0%。最大股东为 VANGUARD GROUP INC，持股比例 11.88%。内部人员持股约 1.20%。数据来源 SEC Form 13F，截至 September 30, 2025。